Industry

DUBLIN–(BUSINESS WIRE)–The “Dravet Syndrome Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 To 2029” report has been added to ResearchAndMarkets.com’s offering. Industry Outlook Dravet syndrome treatment accounted for a market value of US$ 258.1 Mn in 2020 and projected to grow at a CAGR of … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Chronic Kidney Disease – Market Insight, Epidemiology and Market Forecast -2032” report has been added to ResearchAndMarkets.com’s offering. This “Chronic Kidney Disease- Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Chronic Kidney Disease, historical and forecasted epidemiology as well as the Chronic Kidney Disease market trends in the … [Read more…]

FRANKFURT AM MAIN & LONDON–(BUSINESS WIRE)–Akanda Corp. (“Akanda”) (NASDAQ: AKAN) and Cansativa GmbH (“Cansativa Group”) today jointly announced a new cooperation that will soon allow German pharmacies to provide patients with two novel cannabis cultivars. This collaboration allows the Cansativa platform to supply the German market with dried flowers from Akanda’s EU-GMP certified indoor grow … [Read more…]

A survey of 1,012 UK doctors has found that nearly half of junior doctors intend to pursue non-clinical careers The top reason (37%) is burnout, but this is not directly linked to the COVID-19 pandemic Almost 3 in 10 respondents (29%) mentioned that they would like to make a career change, with female doctors more … [Read more…]

BSI certification agency has granted Abionic’s abioSCOPE® device and PSP test the IVDR certification for in-vitro diagnostics. This certification complies with Europe’s new In-vitro Diagnostic Regulation (IVDR), and will be required for products sold within the EU from May 2022 onward. A transitional regulation allows established, non-IVDR-certified products to be sold and used if they … [Read more…]

TORONTO–(BUSINESS WIRE)–First paragraph, first sentence of release should read: Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) (“Cybin” or the “Company”), a biopharmaceutical company focused on progressing “Psychedelics to TherapeuticsTM”, announced today that it has established an at-the-market equity program (the “ATM Program”) that allows Cybin to issue and sell up to USD$35,000,000 of common shares … [Read more…]

NEW BRUNSWICK, N.J.–(BUSINESS WIRE)–Johnson & Johnson (NYSE: JNJ) (“the Company”) announced today that Mathai Mammen, M.D., Ph.D., has decided to leave his position as Executive Vice President, Pharmaceuticals, R&D, and pursue other opportunities outside of the Company. William Hait, M.D., Ph.D., will serve as interim head of the Pharmaceutical R&D organization until new leadership is … [Read more…]

Approximately 6,000 participants 5 years of age and older will be enrolled in Lyme disease-endemic regions in Europe and the U.S.  NEW YORK & SAINT-HERBLAIN, France–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced the initiation of a Phase 3 clinical study, Vaccine Against Lyme for Outdoor Recreationists (VALOR) … [Read more…]

NASHVILLE, Tenn.–(BUSINESS WIRE)–HCA Healthcare, Inc. (NYSE: HCA), one of the nation’s leading healthcare providers, today announced that it will contribute up to $400,000 in funding, colleague matching and in-kind donations to support organizations providing relief services to eastern Kentucky communities struck by historic flooding. HCA Healthcare will contribute to the following organizations: $100,000 to the … [Read more…]

Prospective Study Earlier Presented at the Annual Meeting of the American Academy of Ophthalmology (AAO) and Selected for Panel Discussion as an Outstanding work. First prospective clinical study on AI and color retinal image-based early diagnosis of AMD in outpatient settings and first such submission to FDA. Study design reviewed with FDA at a pre-submission … [Read more…]